Crossref
A beta oligomerization A Therapeutic Target for Alzheimers Disease
Current Medicinal Chemistry-Immunology, Endocrine & Metabolic Agents · 2001
DOI: 10.2174/1568013013359140 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Medicinal Chemistry-Immunology, Endocrine & Metabolic Agents, 2001. Verfasst von D. Howlett. Die Arbeit wurde bisher 4-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Howlett, D. (2001). A beta oligomerization A Therapeutic Target for Alzheimers Disease. Current Medicinal Chemistry-Immunology, Endocrine & Metabolic Agents. https://doi.org/10.2174/1568013013359140
Vancouver
Howlett D. A beta oligomerization A Therapeutic Target for Alzheimers Disease. Current Medicinal Chemistry-Immunology, Endocrine & Metabolic Agents. 2001. doi:10.2174/1568013013359140
BibTeX
@article{Howlett2001,
author = {Howlett, D.},
title = {A beta oligomerization A Therapeutic Target for Alzheimers Disease},
journal = {Current Medicinal Chemistry-Immunology, Endocrine & Metabolic Agents},
year = {2001},
doi = {10.2174/1568013013359140}
}
EUVIMED